Skip to content
A1982Assembly2021-2022 Session

Stop Epilepsy Drug Swaps

Official title

“Prohibits a pharmacist from substituting any anti-epileptic drug for a prescribed anti-epileptic drug without the informed consent of the prescriber and patient”

Sponsor Jeffrion AubryAD-35Affects Education
Status
In Assembly Committee
Higher Education
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires pharmacists to obtain both prescriber and patient consent before substituting any anti-epileptic drug or formulation.

Why it matters

  1. Increases patient safety and oversight. By requiring both prescriber and patient consent before switching any anti-epileptic drug (including between generics or formulations), the bill aims to reduce the risk of breakthrough seizures or adverse effects that can occur when epilepsy medications are changed without close monitoring.

  2. Limits pharmacist discretion for epilepsy drugs. Pharmacists will no longer be able to make automatic substitutions for anti-epileptic drugs (as is common for many medications), ensuring that even seemingly minor changes—such as switching between generic manufacturers—require explicit approval from the prescriber and patient.

  3. Strengthens patient autonomy and informed consent. Patients (or their guardians) must be directly notified and must provide signed, informed consent before any substitution can be made, empowering them to be active participants in their treatment and reducing the chance of changes being made without their knowledge.

  4. Exception to broader generic substitution rules. The bill specifically carves out epilepsy drugs as an exception to New York’s general policy of favoring generic substitution to lower costs, recognizing the unique risks and sensitivities associated with seizure medications.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Stop Epilepsy Drug Swaps

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jeffrion Aubry

Assembly Member · Assembly District 35

History

  1. Referred to higher education
  2. Referred to higher education

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1982

2021-2022 Regular Sessions

IN ASSEMBLY

January 14, 2021

Introduced by M. of A. AUBRY -- Multi-Sponsored by -- M. of A. BENEDET- TO, CAHILL, COLTON, PERRY, J. RIVERA, L. ROSENTHAL, THIELE -- read once and referred to the Committee on Higher Education

AN ACT to amend the public health law and the education law, in relation to requiring notification of and the informed consent of the prescriber and the patient prior to the substitution of a prescribed anti-epileptic drug

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 3346 to read as follows:

§ 3346. Anti-epileptic drug product selection prohibited. 1. As used in this section:

(a) "Anti-epileptic drug" means (i) any drug prescribed for the treatment of epilepsy or (ii) a drug used to treat or prevent seizures.

(b) "Epilepsy" means a neurological condition characterized by recurrent seizures.

(c) "Seizure" means an acute clinical change secondary to a brief disturbance in the electrical activity of the brain.

(d) "Interchange" means the substitution of one version of the same anti-epileptic therapeutic product, including a generic version for the prescribed brand, a brand version for the prescribed generic version, a generic version by one manufacturer for a generic version by a different manufacturer, a different formulation of the prescribed anti-epileptic drug or a different anti-epileptic therapeutic drug product for the anti-epileptic product originally prescribed.

2. No pharmacist shall interchange an anti-epileptic drug or formulation of an anti-epileptic drug, brand or generic, for the treatment of epileptic seizures without the prior notification of and the signed informed consent of such interchange from the prescribing physician and the patient, or the patient's parent, legal guardian or spouse.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00447-01-1

A. 1982 2

§ 2. The opening paragraph of subdivision 1 of section 6816-a of the education law, as added by chapter 776 of the laws of 1977, is amended to read as follows:

[A] Except as provided in section thirty-three hundred forty-six of the public health law, a pharmacist shall substitute a less expensive drug product containing the same active ingredients, dosage form and strength as the drug product prescribed, ordered or demanded, provided that the following conditions are met:

§ 3. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.